Literature DB >> 21275965

Higher risk of primary cancers after polycythaemia vera and vice versa.

Mahdi Fallah, Elham Kharazmi, Jan Sundquist, Kari Hemminki.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21275965     DOI： 10.1111/j.1365-2141.2010.08538.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  Current applications of therapeutic phlebotomy.

Authors:  Tarek Bou Assi; Elizabeth Baz
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database.

Authors:  Andrew M Brunner; Gabriela Hobbs; Marla M Jalbut; Donna S Neuberg; Amir T Fathi
Journal:  Leuk Lymphoma       Date:  2015-08-19

3.  The role of parathyroidectomy in JAK2 mutation negative polycythemia vera.

Authors:  Afif N Kulaylat; Eric E Jung; Brian D Saunders
Journal:  Int J Hematol       Date:  2014-09-11       Impact factor: 2.490

4.  Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia.

Authors:  Cristina Santoro; Isabella Sperduti; Roberto Latagliata; Erminia Baldacci; Barbara Anaclerico; Giuseppe Avvisati; Massimo Breccia; Francesco Buccisano; Michele Cedrone; Giuseppe Cimino; Cinzia De Gregoris; Marianna De Muro; Ambra Di Veroli; Sabrina Leonetti Crescenzi; Marco Montanaro; Enrico Montefusco; Raffaele Porrini; Angela Rago; Antonio Spadea; Francesca Spirito; Nicoletta Villivà; Alesssandro Andriani; Giuliana Alimena; Maria Gabriella Mazzucconi
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

5.  Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data.

Authors:  Arianna Ghirardi; Alessandra Carobbio; Arianna Masciulli; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-16       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.